From April 24 to April 25, 2009, Daiwa Pharmaceutical, along with its US-based affiliate Daiwa Health Development Inc., participated in the 17th Annual World Congress on Anti-Aging Medicine held in Orlando, Florida.

This congress, held by the American Academy of Anti-Aging Medicine, targeted primarily doctors and had more than 300 participating companies. There was once again a high turnout of doctors and researchers both from the US and from other countries that visited Gaylord Palms Hotels Florida, the venue for this year's congress.

Daiwa Pharmaceutical exhibited “BRM4” (250 mg and 500 mg) and “Plasmanex 1”, our leading products in the US. Daiwa Pharmaceutical also made a presentation by Dr. Raif Tawakol, who described the relationship between metabolic syndrome and blood coagulation and its preventive measures, in a presentation titled “Diabetes: Glucose Wars can be Won and Lost on the Battlegrounds of Coagulation and Immunity”.

Dr. Shari Lieberman also delivered a lecture on “The Science behind RBAC (BRM4)” and gave a summary of his paper on RBAC (BioBran). Many people attended the presentations and were enthusiastically asking questions, showing a high level of interest in our products.

Both of the products have gained an excellent reputation among health care providers. In response, Daiwa Pharmaceutical will continue with even greater effort to provide our customers with reliable and safe products backed by solid evidence.

・

Copyright(C)2009 Daiwa Pharmaceutical Co.,Ltd. All rights reserved. | HOME >